Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines

E.coli is an attractive system for building glycoconjugate vaccine candidates. @LSHTM use tools from @ATUM_bio to add/remove components of Streptococcus pneumoniae capsular polysaccharides for the production of glycosylated vaccines in E.coli https://t.co/